Infectious Diseases in Critical Care Medicine

17. Rodriguez SC, Olguin Am, Miralles CP, et al. Characteristics of meningitis caused by Ibuprofen:
    report of 2 cases with recurrent episodes and review of the literature. Medicine 2006; 85:214–220.


18. Roos KL. Pearls and pitfalls in the diagnosis and management of the central nervous system in
    infectious diseases. Semin Neurol 1998; 18:185–196.


19. Warnatz K, Peter HH, Schumacher M, et al. Infectious CNS disease as a differential diagnosis in
    systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis 2003; 62:
    50–57.


20. Carsons SE, Belilos E. Mimics of central nervous system infections. In: Cunha BA, ed. Infectious
    Diseases in Critical Care Medicine. New York: Marcel Dekker, 1998:181–189.


21. Sanna G, Bertolaccini ML, Mathieu A. Central nervous system lupus: a clinical approach to therapy.
    Lupus 2003; 12:935–942.


22. Hadfield MG, Aydin F, Lippman HR, et al. Neuro-Behc ̧et’s disease. Clin Neuropathol 1997; 16:55–60.


23. James DG, Williams WJ. Sarcoidosis and Other Granulomatous Disorders. Philadelphia: W.B.
    Saunders, 1985.


24. Sharma OP. Sarcoidosis. Clinical Management. London: Butterworths, 1984.


25. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493
    episodes. N Engl J Med 1993; 328:21–28.


26. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in
    adults with suspected meningitis. N Engl J Med 2001; 345:1727–1733.


27. Tyler KL, Martin JB. Infectious Diseases of the Central Nervous System. Philadelphia: FA Davis
    Company, 1993.


28. Pruitt AA. Nervous system infections in patients with cancer. Neurol Clin 2003; 21:193–219.


29. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002; 20:85–122.


30. Cunha BA. The diagnostic significance of the CSF lactic acid. Infect Dis Pract 1997; 21:57–60.


31. Bailey EM, Domenico P, Cunha BA. Bacterial versus viral meningitis. The importance of CSF lactic
    acid. Postgrad Med 1990; 88:217–223.


32. Cunha BA. The usefulness of CSF lactic acid levels in central nervous system infections with
    decreased cerebrospinal fluid glucose. Clin Infect Dis 2004; 39:1260–1261.


33. Latcha S, Cunha BA.Listeria monocytogenesmeningoencephalitis: the diagnostic importance of the CSF
    lactic acid. Heart Lung 1994; 23:177–179.


34. Cunha B, Fatehpuria R, Eisenstein LE.Listeria monocytogenesencephalitis mimicking herpes simplex
    (HSV) encephalitis: the differential diagnostic importance of CSF lactic acid levels. Heart & Lung
    2007; 36:226–231.


35. Shimentani N, Shimetani K, Mori M. Levels of three inflammation markers, C-reactive protein, serum
    amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with
    meningitis. Scand J Clin Lab Invest 2001; 61:567–574.


36. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: W.B.
    Saunders, 1992.


37. Knudsen TB, Larsen K, Kristiansen TB, et al. Diagnostic value of soluble CD163 serum levels in
    patients suspected of meningitis: comparison with CRP and procalcitononin. Scand J Infect Dis 2007; 39:
    543–553.


38. Dubos F, Moulin F, Gajdos V, et al. Serum procalcitonin and other biologic markers to distinguish
    between bacterial and aseptic meningitis. J Pediatr 2006; 149:72–76.


39. Cunha BA, Sachdev B, Canario D. Serum ferritin levels in West Nile encephalitis. Clin Microbiol Infect
    2004; 10:184–186.


40. Cunha BA. West Nile encephalitis: clinical diagnostic and prognostic indicators in compromised
    hosts. Clin Infect Dis 2006; 42:117.


41. McCullers JA, Lakeman FD, Whitley RJ. Human Herpesvirus 6 is associated with focal encephalitis.
    Clin Infect Dis 1995; 21:571–576.


42. Cunha BA. Antibiotic Essentials. 8th ed. Sudbury, MA: Jones & Bartlett, 2009.


43. Aronin SI. Bacterial meningitis: principles and practical aspects of therapy. Curr Infect Dis Rep 2000;
    2: 337–344.


44. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997; 336:708–716.


45. van de Beek D, de Gans J, Tunkel AR, et al. Communit-acquired bacterial meningitis in adults. N Engl
    J Med 2006; 354:44–53.


46. Schut ES, de Gans J, van de Beek. Community-acquired bacterial meningitis in adults. Pract Neurol
    2008; 8:8–23.


47. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am 2008; 26:281–317.


48. Weisfelt M, de Gans J, van de Beek D. Bacterial meningitis: a review of effective pharmacotherapy.
    Expert Opin Pharmacother 2007; 8:1493–1504.

Meningitis and Its Mimics in Critical Care 151